Montag A & Associates Inc Eli Lilly & CO Transaction History

Montag A & Associates Inc

$2.09 Billion
Q3 2024

A detailed history of Montag A & Associates Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Montag A & Associates Inc holds 28,614 shares of LLY stock, worth $21.5 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares

28,614

Previous 27,351 4.62%

Holding current value

$21.5 Million

Previous $24.8 Million 2.37%

% of portfolio

1.21%

Previous 1.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$772.14 - $960.02 $975,212 - $1.21 Million	1,263 Added 4.62%	28,614 $25.4 Million
Q2 2024 Jul 31, 2024	SELL	$724.87 - $909.04 $300,821 - $377,251	-415 Reduced 1.49%	27,351 $24.8 Million
Q1 2024 May 07, 2024	SELL	$592.2 - $792.28 $737,289 - $986,388	-1,245 Reduced 4.29%	27,766 $21.6 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $444,835 - $524,403	-847 Reduced 2.84%	29,011 $16.9 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $254,734 - $351,189	-586 Reduced 1.92%	29,858 $16 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $1.36 Million - $1.82 Million	-3,887 Reduced 11.32%	30,444 $14.3 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $1.29 Million - $1.51 Million	-4,138 Reduced 10.76%	34,331 $11.8 Million
Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $481,360 - $560,880	-1,497 Reduced 3.75%	38,469 $14.1 Million
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $252,008 - $287,189	-850 Reduced 2.08%	39,966 $12.9 Million
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $129,051 - $151,526	-463 Reduced 1.12%	40,816 $13.2 Million
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $47,407 - $58,915	-202 Reduced 0.49%	41,279 $11.8 Million
Q4 2021 Feb 09, 2022	BUY	$224.85 - $279.04 $3.22 Million - $4 Million	14,320 Added 52.72%	41,481 $11.5 Million
Q3 2021 Nov 08, 2021	SELL	$221.6 - $272.71 $89,526 - $110,174	-404 Reduced 1.47%	27,161 $6.28 Million
Q2 2021 Aug 03, 2021	SELL	$180.55 - $233.54 $257,283 - $332,794	-1,425 Reduced 4.92%	27,565 $6.33 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $5,422 - $7,019	33 Added 0.11%	28,990 $5.42 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $1,435 - $1,898	-11 Reduced 0.04%	28,957 $4.89 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $29,244 - $33,826	-200 Reduced 0.69%	28,968 $4.29 Million
Q2 2020 Aug 04, 2020	SELL	$136.42 - $164.18 $13,641 - $16,418	-100 Reduced 0.34%	29,168 $4.79 Million
Q1 2020 May 06, 2020	SELL	$119.05 - $147.35 $631,322 - $781,397	-5,303 Reduced 15.34%	29,268 $4.06 Million
Q4 2019 Feb 05, 2020	SELL	$106.92 - $132.43 $160,380 - $198,645	-1,500 Reduced 4.16%	34,571 $4.54 Million
Q3 2019 Nov 04, 2019	SELL	$106.79 - $116.16 $158,262 - $172,149	-1,482 Reduced 3.95%	36,071 $4.03 Million
Q2 2019 Aug 06, 2019	SELL	$110.79 - $129.32 $2.7 Million - $3.15 Million	-24,355 Reduced 39.34%	37,553 $4.16 Million
Q1 2019 May 01, 2019	SELL	$111.31 - $131.02 $3.34 Million - $3.93 Million	-30,010 Reduced 32.65%	61,908 $8.03 Million
Q4 2018 Feb 06, 2019	SELL	$105.9 - $118.64 $188,290 - $210,941	-1,778 Reduced 1.9%	91,918 $10.6 Million
Q3 2018 Nov 07, 2018	BUY	$85.86 - $107.31 $4.74 Million - $5.92 Million	55,180 Added 143.27%	93,696 $10.1 Million
Q2 2018 Aug 01, 2018	SELL	$75.7 - $86.88 $20,817 - $23,892	-275 Reduced 0.71%	38,516 $3.29 Million
Q1 2018 May 07, 2018	SELL	$74.21 - $87.6 $128,086 - $151,197	-1,726 Reduced 4.26%	38,791 $3 Million
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $135,119 - $144,930	-1,649 Reduced 3.91%	40,517 $3.42 Million
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $3.25 Million - $3.61 Million	42,166	42,166 $3.61 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.

Account

Montag A & Associates Inc Eli Lilly & CO Transaction History